Institut Paoli Calmettes - Hôpital de jour

Marseille, Bouches-du-Rhône 13273

0 studies enrolling now · 2 studies all time

What they study most

Advanced and Metastatic Urothelial Cancer, Renal Cell Carcinoma

Studies at this site

• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma — Stopped early